From Yahoo Finance: 2025-04-15 10:06:00

BofA lowered West Pharmaceutical’s price target to $280 from $285, citing negative sentiment in Life Sciences and Diagnostic Tools sectors due to potential policy changes. Analysts warn of headwinds from NIH budget cuts, global tariffs, and broader macro concerns like China. Investors should be cautious heading into earnings.

Read more: West Pharmaceutical price target lowered to $280 from $285 at BofA